Hostname: page-component-89b8bd64d-72crv Total loading time: 0 Render date: 2026-05-09T17:35:04.631Z Has data issue: false hasContentIssue false

How are US institutions implementing the new key information requirement?

Published online by Cambridge University Press:  10 January 2020

Jessica Mozersky
Affiliation:
Bioethics Research Center, Washington University School of Medicine, Box 8005, St. Louis, MO, USA
Matthew P. Wroblewski
Affiliation:
Bioethics Research Center, Washington University School of Medicine, Box 8005, St. Louis, MO, USA
Erin D. Solomon
Affiliation:
Bioethics Research Center, Washington University School of Medicine, Box 8005, St. Louis, MO, USA
James M. DuBois*
Affiliation:
Bioethics Research Center, Washington University School of Medicine, Box 8005, St. Louis, MO, USA
*
Address for correspondence: J. M. DuBois, PhD, ScD, Washington University School of Medicine, Bioethics Research Center, Division of General Medical Sciences, 4523 Clayton Avenue, Box 8005, St. Louis, MO, 63110, USA. Email: duboisjm@wustl.edu
Rights & Permissions [Opens in a new window]

Abstract

Recent revisions to the Federal Policy for the Protections of Human Subjects require that informed consent documents begin with a “concise and focused presentation” of the key information a participant requires. Key information “must be organized and presented in a way that facilitates comprehension.” The regulations do not specify what information be included, nor how it must be presented to facilitate comprehension. It is unknown how institutions and Institutional Review Boards (IRBs) are interpreting the current regulations. We conducted a review of randomly sampled available key information templates at 46 US medical institutions to determine how they are implementing the new regulations.

Information

Type
Brief Report
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Association for Clinical and Translational Science 2020
Figure 0

Table 1. Regulatory guidance framework definitions

Figure 1

Table 2. Regulatory guidance contained in key information templates

Figure 2

Table 3. Frequencies and percentages of specific content topics contained in key information templates

Figure 3

Table 4. Frequencies and percentages of health communication best practices guidance

Supplementary material: File

Mozersky et al. supplementary material

Mozersky et al. supplementary material

Download Mozersky et al. supplementary material(File)
File 21.1 KB